Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
BlueFive targets $3bn fund to tap booming Middle East defence market
BlueFive targets $3bn fund to tap booming Middle East defence market BlueFive Capital is planning to raise $3bn for a new defence-focused private equity fund, as the firm seeks to capitalise on rising military expenditure across the Middle East, according to...
EQT restarts $1bn sale of Ginko China unit after Advent exit
EQT restarts $1bn sale of Ginko China unit after Advent exit EQT has restarted the sale process for the China business of contact lens maker Ginko, targeting a valuation of at least $1bn, Reuters reports. The renewed process follows a failed sale to Advent...
Jane Street, Situational Awareness target $18bn Fluidstack valuation in $1bn raise
Jane Street, Situational Awareness target $18bn Fluidstack valuation in $1bn raise Jane Street and Situational Awareness are in talks to co-lead a $1bn funding round for Fluidstack, valuing the cloud infrastructure company at approximately $18bn, according to...